Brief: Amphastar Pharmaceuticals posts Q1 EPS USD 0.5
09/05/2023 21:10
May 9 (Reuters) - Amphastar Pharmaceuticals Q1 adjusted EPS USD 0.62. * Q1 EPS USD 0.5 * Q1 adjusted net income USD 32.143 million * Q1 net income USD 26.032 million * Q1 revenue USD 140.022 million
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing